Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease - Related Studies

Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease

This study has been completed.

Study NCT00025896. Last updated on July 16, 2007. Information provided by Genzyme

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pompe Disease
		Glycogen Storage Disease Type II
		Acid Maltase Deficiency Disease
		Glycogenosis 2

2	Additional conditions recognized in this trial
		Deficiency Diseases
		Glycogen Storage Disease

3	More general conditions related to this trial
		Brain Diseases
		Brain Diseases, Metabolic
		Brain Diseases, Metabolic, Inborn
		Carbohydrate Metabolism, Inborn Errors
		Central Nervous System Diseases
		Genetic Diseases, Inborn
		Lysosomal Storage Diseases
		Lysosomal Storage Diseases, Nervous System
		Malnutrition
		Metabolic Diseases
		Metabolism, Inborn Errors
		Nervous System Diseases
		Nutrition Disorders

4	Sponsors listed in this trial
		Genzyme